跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ALPHAGAN Brimonidone tartrate 2mg/mL eye drop bottle - TGA Drug Approval Details
Approvals
/
TGA
/
ALPHAGAN Brimonidone tartrate 2mg/mL eye drop bottle
Approved
STANDARD
ALPHAGAN Brimonidone tartrate 2mg/mL eye drop bottle
AbbVie Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
a517eeaaedaa42f0
Company
AbbVie Pty Ltd
Type
Standard
Approval Details
Approval Id
a517eeaaedaa42f0
Product Name
ALPHAGAN Brimonidone tartrate 2mg/mL eye drop bottle
Artg Id
60297
Artg Name
ALPHAGAN brimonidine tartrate 2mg/mL eye drop bottle
Sponsor
AbbVie Pty Ltd
Company Detail Path
/organization/abbvie-pty-ltd
Artg Date
1997-11-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/6bdde2da99b8cf3fca7eb11e9abf712b.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/8c0d995817e0f1355980dda859ec15fd.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
a517eeaaedaa42f0
Type
Standard
Back to TGA Approvals